ADH1A and pancreatic adenocarcinoma: High expression of ADH1A or ADH6 was predictive of improved prognosis for pancreatic adenocarcinoma [185], and high expression of ADH1A or ADH4 had improved prognosis for non-small cell lung cancer [186].